Tuesday, September 15, 2026

Discover aespa’s Unique Solo Songs: A Deep Dive into SYNK: COMPLaeXITY and Its Impact

K-pop group aespa releases solo tracks from their concert as official audio, continuing the excitement for fans.

Kia’s Tasman Teaser Drops: A New Pickup Born from 18,000 Trials

Today, Kia announced the release of a teaser video series, "One More Round," highlighting the development process of Tasman.

Daughter of Dictator: Kim Jong Un’s Daughter Makes Rare Appearance: Is She the Next Leader of North Korea?

Kim Ju-ae's public appearances hint at a possible future role, but evidence suggests she may not be groomed as a successor yet.

News1

Author's Latest

How Puppy Videos Help Manage Blood Pressure: A Groundbreaking Study for Office Workers

Research suggests that dog videos can help manage cardiovascular and mental health in chronically stressed workers by evoking emotional responses.

200 Successful Treatments: How Lu-177 PSMA Therapy is Revolutionizing Prostate Cancer Care in South Korea

The Catholic University Seoul St. Mary's Hospital's Urology Cancer Center achieves 200 cumulative treatments for metastatic prostate cancer.

EverEx’s MORA Solutions: Revolutionizing Musculoskeletal Care with AI in 2026

EverEx, a digital healthcare company, accelerates expansion with strategic investments from domestic pharma and tech firms.

SK Biopharmaceuticals’s Opakalim: Targeting U.S. Launch in 2029—How Effective Is It at Suppressing Seizures?

SK Biopharmaceuticals takes a significant step with its epilepsy drug candidate Opakalim (BHV-7000) as it addresses the Xcopri one-tool challenge.

DaeWoong’s Nabota: The Korean Botox Revolutionizing the Global Aesthetic Market

Botox is often the first treatment that comes to mind for skin wrinkles, but it's actually a brand name for botulinum toxin.

AbClon Secures Japanese Patent for Dual-Antibody Cancer Drug AM105: What This Means for Global Markets

AbClon has completed the registration of a Japanese patent for its next-generation dual antibody immuno-oncology candidate AM105.

CS5001: 100% Complete Response Rate in DLBCL Clinical Trial – A Game Changer for Cancer Treatment?

LigaChem Biosciences reveals clinical data for cancer drug CS5001 targeting DLBCL, developed in partnership with CStone Pharmaceuticals.

CS5001 Breakthrough: 100% Complete Remission in DLBCL Trials – What This Means for Cancer Treatment

ABL Bio's ADC candidate shows complete response in all patients in early trials for first-line treatment of DLBCL.

Deep Neuro BrainSeg: Revolutionizing Brain MRI Analysis for Enhanced Diagnosis in 2026

Deepnoid expands its medical AI solutions by adding automated MRI analysis for brain volume assessment, aiding in brain disease diagnosis.

Unlocking Innovation: How the 2026 KDDF Science Conference is Shaping the Future of Drug Development

Innovation in drug development arises from collaboration among scientists across various fields sharing knowledge and experience.

Krafton to Evaluate How Candidates Work With AI, Including Their Prompts

Krafton’s AI-native hiring solution evaluates not just candidates’ final outputs, but also how they collaborate with AI—including prompts, decision-making, verification, and error recovery.

AI Predicts Dementia Risk From a Single Eye Photo, Korean Researchers Develop Model

Korean researchers have developed an AI model that can screen for current dementia and predict future dementia risk using only retinal fundus photographs.

Discover Daewoong Alliance: How Digital Healthcare is Transforming Patient Care in 2026

Daewoong Pharmaceutical accelerates business expansion by collaborating with domestic digital healthcare firms using medical data and AI.

Novo Nordisk Launches Clinical Trials for Next-Gen Obesity Drug ZenaGamtide in Asia: What to Expect?

Novo Nordisk begins domestic Phase 3 trials for obesity treatment candidate ZenaGamtide, competing with Eli Lilly's market leader.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.